A Randomized Phase 2 Study of Paclitaxel and Carboplatin With or Without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

A Randomized Phase 2 Study of Paclitaxel and Carboplatin With or Without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer / Paz Ares, A., Bálint, B., de Boer, R.h., van Meerbeeck, J.p., Wierzbicki, R., De Souza, P., Galimi, F., Haddad, V., Sabin, T., Hei, Y., Pan, Y., Cottrell, S., Hsu, C.p., Ramlau, R.. - In: JOURNAL OF THORACIC ONCOLOGY. - ISSN 1556-0864. - 8:3(2013), pp. 329-337. [10.1097/JTO.0b013e31827ce554]